# Social cognition and interactive training for first-episode, drug-naïve MDD patients

**Authors:** Jiaxin Li, Ru Li, Dazhi Li, Shiyi Suzy Ji, Xingguang Luo, Yong Zhang

PMC · DOI: 10.3389/fpsyt.2025.1566811 · Frontiers in Psychiatry · 2025-10-15

## TL;DR

This study found that social cognition and interaction training improved social functioning and was linked to increased GDNF levels in first-time depression patients.

## Contribution

The study introduces SCIT as a novel therapy showing greater functional improvement and biological correlation compared to CBT in FEDN MDD patients.

## Key findings

- SCIT significantly improved psychosocial function more than CBT in multiple domains.
- Changes in GDNF levels correlated with improvements in autonomy and financial domains after SCIT.
- SCIT demonstrated strong statistical significance in cognitive and interpersonal functioning improvements.

## Abstract

This study aimed to explore the impacts of social cognition and interaction training (SCIT) on serum brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF) levels, and psychosocial function in first-episode, drug-naïve (FEDN) major depressive disorder (MDD) patients.

In this 8-week randomized controlled trial (RCT), 45 MDD patients were assigned to SCIT group and 39 to cognitive behavioral therapy (CBT) group. The 17-item Hamilton Rating Scale (HDRS-17) and the Functioning Assessment Short Test (FAST) were performed to measure depressive symptoms and functional impairment severity, respectively. We also collected blood samples for serum BDNF/GDNF level detection.

Compared to CBT, SCIT demonstrated significantly greater improvements in total FAST scores (F (1,82) = 109.21, p < 0.001, 
ηp2 = 0.57
); especially in occupational (F (1,82) = 16.69, p < 0.001, 
ηp2=0.17
); cognitive (F (1,82) = 103.51, p < 0.001, 
ηp2=0.56
), and interpersonal relationship domains (F (1,82) =65.07, p < 0.001, 
ηp2=0.44
). Changes in serum GDNF levels were positively associated with changes in autonomy (r (40) = 0.32, 95% CI = [0.02, 0.57], p = 0.038), and financial domains (r (40) = 0.44, 95% CI = [0.15, 0.65], p = 0.004) in SCIT group.

Improvements in social function through SCIT can be effectively generalized to MDD patients. Moreover, improved GDNF levels were associated with improvements in specific aspects of social functioning post-SCIT.

## Linked entities

- **Proteins:** BDNF (brain derived neurotrophic factor), GDNF (glial cell derived neurotrophic factor)
- **Diseases:** major depressive disorder (MONDO:0002009), MDD (MONDO:0012048)

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, GDNF (glial cell derived neurotrophic factor) [NCBI Gene 2668] {aka ATF, ATF1, ATF2, HFB1-GDNF, HSCR3}
- **Diseases:** MDD (MESH:D003865), depressive symptoms (MESH:D003866)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12568539/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12568539/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12568539/full.md

---
Source: https://tomesphere.com/paper/PMC12568539